We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

How Researchers Are Bringing Sustainability to Scientific Discovery
Industry Insight

How Researchers Are Bringing Sustainability to Scientific Discovery

Research is advancing exciting areas of science at an unprecedented pace, but the disposable materials, powered equipment and shipping associated with experiments, sample storage and transport of reagents contribute to high energy consumption and significant waste. How are researchers bringing sustainability to scientific discovery?
Cancer Research Horizons: Driving Innovation and Strengthening Academia–Industry Collaboration
Industry Insight

Cancer Research Horizons: Driving Innovation and Strengthening Academia–Industry Collaboration

In April 2022, Cancer Research UK unveiled Cancer Research Horizons, its new approach to driving innovation in the field. Technology Networks had the opportunity to speak with two members of Cancer Research Horizon’s executive leadership team to learn more about some of the cutting-edge experimental capabilities that will be used to interrogate cancer biology more thoroughly.
Molecular Spectroscopy Evolves To Meet Changing Pharma and Biopharma Needs
Industry Insight

Molecular Spectroscopy Evolves To Meet Changing Pharma and Biopharma Needs

We spoke to Geoff Winkett and Michel van den Berge from Agilent, about the concerns they hear from their customers in the pharmaceutical and biopharmaceutical sector and how they are helping to address them.
Shielding Oncolytic Viruses From the Immune System To Improve Cancer Treatment
Industry Insight

Shielding Oncolytic Viruses From the Immune System To Improve Cancer Treatment

While oncolytic virus (OV) therapy has garnered increasing attention from the cancer research community, this therapeutic strategy doesn’t come without its challenges, as a patient’s immune system can sometimes mount a response to the OVs before they reach their intended target. To address this, Calidi Biotherapeutics has developed cell-based platforms to shield OVs from the immune system, so that they can effectively target and destroy the cancer cells.
Developing Therapeutics for Huntington’s Disease: Challenges, Opportunities and the Future
Industry Insight

Developing Therapeutics for Huntington’s Disease: Challenges, Opportunities and the Future

Dr. Christian Landles explains why it is so challenging to develop therapeutics for rare diseases such as HD, and discusses the potential of approaches that target mutant huntingtin protein to improve treatment options for HD patients.
Driving Forward Huntington’s Disease Research
Industry Insight

Driving Forward Huntington’s Disease Research

Dr. Christian Landles highlights some of the progress made in recent years to improve our understanding of HD and its drivers.
New Model Will Support Drug Discovery for Liver Disease NASH
Industry Insight

New Model Will Support Drug Discovery for Liver Disease NASH

To learn more about NASH “in-a-box” and how it can help to advance drug discovery for NASH, Technology Networks spoke to Dr. Audrey Dubourg.
The Spotlight on mRNA: A Conversation With Moderna
Industry Insight

The Spotlight on mRNA: A Conversation With Moderna

Technology Networks had the pleasure of interviewing Sunny Himansu M.B.B.S., D.SM – associate director, infectious diseases at Moderna – to discuss the biotech company's pipeline, how a collaboration with IAVI aims to make mRNA-based preventives and therapeutics globally accessible and the future of mRNA in medicine.
Investing in the Future of Our People and Our Planet Through Science
Industry Insight

Investing in the Future of Our People and Our Planet Through Science

We spoke to Geoff Winkett and Michel van den Berge from Agilent, about the importance of fostering academia–industry relationships and how the issue of sustainability is shaping the way they approach the development of new and existing solutions.
Live Biotherapeutics ‒ A Novel Way To Treat Disease
Industry Insight

Live Biotherapeutics ‒ A Novel Way To Treat Disease

The intricate and intertwined nature of the host‒microbiota connection has garnered increasing interest from the scientific community in recent years, due to its known role in the development and progression of various diseases. 4D pharma has leveraged growing knowledge in the field, by creating a novel class of medicines called live biotherapeutic products (LBPs).
Advertisement